Biocentis
We are a biotechnology company developing ground-breaking solutions to control the world’s most dangerous insect species
Biocentis is an Imperial College London spin-out on a mission to develop eco-friendly genetic solutions to effectively and safely control the dangerous insect species that spread disease to humans, reduce biodiversity, or threaten food security.
We leverage CRISPR to develop self-limiting gene drive technologies that are biological, environmentally friendly, and can be tailored to obtain levels of control that are suitable for a broad range of applications.
Building on a unique proprietary technological platform, invented by our founders at Imperial College London and applicable to all insect species, Biocentis aims to re-imagine the future of biocontrol.
We want to empower communities around the world to tackle the most dangerous insect vectors of disease, to preserve biodiversity and to protect agricultural crops from harmful insect pests. Our vision is a more sustainable world, capable of feeding a growing population and free of vector-borne disease.
- Totale raccolto
- 11 Mln €
- Round
- 1
- Ultimo round
- Seed
Team
Nessun founder mappato su questa scheda. Aggiungili
Investitori
- Algebris
- Grantham Foundation for the Protection of the Environment
- Neurone
Round di finanziamento
1 round · 11.000.000 € raccolti.
| Data | Round | Importo | Fonte |
|---|---|---|---|
| 19 nov 2025 | Seed | 11.000.000 € | annuncio |
